Testing PD-1 Inhibition With Neoadjuvant Anti-HER2 Therapy in Breast Cancer
At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported on a…
Browsing Tag
antiHER2
Novel Anti-HER2 Drugs ‘Impressive’ in Advanced Biliary Cancer
CHICAGO -- In a pair of mid-stage trials, newer targeted therapies demonstrated meaningful levels of activity…
Voyager Therapeutics Announces Positive Preclinical Data from New Vectorized…
Novel intravenous (IV) vectorized antibody approach designed to activate innate immune system, destroy metastatic breast cancer tumors, and inhibit tumor progression in CNS Proprietary…